2011 年的骨癌：预防和治疗骨转移。
Bone cancer in 2011: Prevention and treatment of bone metastases.
机构信息
Sheffield Cancer Research Center, Academic Unit of Clinical Oncology, Weston Park Hospital, Whitham Road, Sheffield S10 2SJ, UK.
出版信息
Nat Rev Clin Oncol. 2011 Dec 20;9(2):76-8. doi: 10.1038/nrclinonc.2011.198.
PMID:22182971
Abstract
Bone-targeting treatments have transformed the quality of life of patients with metastatic bone disease. 2011 saw the emergence of denosumab—a RANK ligand-specific antibody—as a more-effective alternative treatment to bisphosphonates and of data on the use of bone-targeting treatments to prevent metastasis from breast and prostate cancers.
摘要
骨靶向治疗改变了转移性骨病患者的生活质量。2011 年，出现了 denosumab——一种 RANK 配体特异性抗体——作为比双膦酸盐更有效的替代治疗药物，以及关于使用骨靶向治疗预防乳腺癌和前列腺癌转移的数据。
Zotero 插件